English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Novartis
Patient Daily
| May 7, 2023
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily
| May 7, 2023
Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Patient Daily
| May 7, 2023
Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Patient Daily
| May 7, 2023
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Carol Ostrow
| Feb 7, 2019
Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara
Press release submission
| Dec 5, 2018
NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
Press releases submission
| May 15, 2018
NOVARTIS: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Carrie Bradon
| Dec 1, 2017
Novartis announces positive results of MONALEESA-7 trial
Trending
+
Pharmaceuticals
Patient Daily
| Nov 21, 2024
Las Olas Wine & Food Festival set for April; ticket sales begin Black Friday
+
Pharmaceuticals
Patient Daily
| Nov 15, 2024
Charlotte event raises $110k for lung cancer fight
+
Community
Patient Daily
| Nov 19, 2024
Babylon Dental Care Associate Dentist Absatz: ‘Older adults should follow the same dental care guidelines as anyone else’
+
Pharmaceuticals
Patient Daily
| Nov 19, 2024
Surgeon General's new report targets persistent health disparities linked to tobacco
1
2
3
»
Last »